Company Reports
Company Reports
Drug Reports
Drug Reports
Disease Reports
Disease Reports
Sets
Sets
Favorites
Favorites
Log in
Log in
About
Pricing
Company Reports
Adams Respiratory Therapeutics
Adams Respiratory Therapeutics
(ARXT)
Download report
Favorite
Financial
Marketed Drugs
Clinical Trials
Financial
Stock price
*Currency in USD
Company Revenue
No data
Revenue by Drug
Marketed Drugs
No data
Clinical Trials
Therapeutic Areas:
All
Classification:
All
Approval:
All
Status:
All
Phases:
All
Drug Name
Phase 1
Phase 2
Phase 3
Phase 4
Indication
Erdosteine
chronic obstructive pulmonary disease
,
lung diseases
,
obstructive lung diseases
Lotamilast
depression
,
major depressive disorder
,
epilepsy
,
reflex epilepsy
Remetinostat
depression
,
major depressive disorder
,
epilepsy
,
reflex epilepsy
Tiratricol
respiratory tract infections
,
infections
,
sinusitis
,
bronchitis
,
rhinosinusitis
Usistapide
metabolic syndrome
,
nutritional and metabolic diseases
,
obesity
,
metabolic diseases
,
overweight
,
nutrition disorders
,
type 2 diabetes mellitus
,
diabetes mellitus
,
body weight
,
endocrine system diseases
,
depression
,
major depressive disorder
,
epilepsy
,
reflex epilepsy
© 2020-2025 Collaborative Drug Discovery Inc. (CDD) |
Terms of Use